nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—embryo—polycystic ovary syndrome	0.0442	0.0955	CbGeAlD
Auranofin—PRDX5—adrenal cortex—polycystic ovary syndrome	0.0362	0.0783	CbGeAlD
Auranofin—PRDX5—endometrium—polycystic ovary syndrome	0.0323	0.0699	CbGeAlD
Auranofin—PRDX5—uterus—polycystic ovary syndrome	0.0298	0.0644	CbGeAlD
Auranofin—PRDX5—pituitary gland—polycystic ovary syndrome	0.0292	0.0633	CbGeAlD
Auranofin—PRDX5—adipose tissue—polycystic ovary syndrome	0.0291	0.063	CbGeAlD
Auranofin—IKBKB—embryo—polycystic ovary syndrome	0.0261	0.0566	CbGeAlD
Auranofin—PRDX5—adrenal gland—polycystic ovary syndrome	0.0261	0.0565	CbGeAlD
Auranofin—PRDX5—female gonad—polycystic ovary syndrome	0.0244	0.0527	CbGeAlD
Auranofin—PRDX5—vagina—polycystic ovary syndrome	0.0242	0.0524	CbGeAlD
Auranofin—PRDX5—endocrine gland—polycystic ovary syndrome	0.0227	0.049	CbGeAlD
Auranofin—IKBKB—endometrium—polycystic ovary syndrome	0.0191	0.0414	CbGeAlD
Auranofin—IKBKB—uterus—polycystic ovary syndrome	0.0176	0.0381	CbGeAlD
Auranofin—IKBKB—pituitary gland—polycystic ovary syndrome	0.0173	0.0375	CbGeAlD
Auranofin—IKBKB—adipose tissue—polycystic ovary syndrome	0.0172	0.0373	CbGeAlD
Auranofin—IKBKB—adrenal gland—polycystic ovary syndrome	0.0155	0.0335	CbGeAlD
Auranofin—IKBKB—female gonad—polycystic ovary syndrome	0.0144	0.0312	CbGeAlD
Auranofin—IKBKB—vagina—polycystic ovary syndrome	0.0143	0.031	CbGeAlD
Auranofin—IKBKB—endocrine gland—polycystic ovary syndrome	0.0134	0.029	CbGeAlD
Auranofin—ALB—adrenal gland—polycystic ovary syndrome	0.00903	0.0195	CbGeAlD
Auranofin—IKBKB—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.0012	0.00222	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FBXO44—polycystic ovary syndrome	0.00116	0.00216	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—UBE2H—polycystic ovary syndrome	0.00116	0.00216	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—TNRC6B—polycystic ovary syndrome	0.00116	0.00215	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—SLC2A4—polycystic ovary syndrome	0.00114	0.00212	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00106	0.00198	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—MTHFR—polycystic ovary syndrome	0.00106	0.00198	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TAB1—polycystic ovary syndrome	0.00106	0.00197	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—FGF18—polycystic ovary syndrome	0.00104	0.00194	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—IGF1—polycystic ovary syndrome	0.00104	0.00193	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—IGF1—polycystic ovary syndrome	0.00104	0.00193	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT2—polycystic ovary syndrome	0.00104	0.00193	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—TAB1—polycystic ovary syndrome	0.00101	0.00189	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—CRP—polycystic ovary syndrome	0.00101	0.00188	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—GAB1—polycystic ovary syndrome	0.000953	0.00177	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000953	0.00177	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00091	0.00169	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—BCL2—polycystic ovary syndrome	0.000907	0.00169	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT2—polycystic ovary syndrome	0.000889	0.00165	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—CAMK2D—polycystic ovary syndrome	0.000881	0.00164	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—MTHFR—polycystic ovary syndrome	0.000866	0.00161	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRG1—polycystic ovary syndrome	0.000866	0.00161	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—TNRC6B—polycystic ovary syndrome	0.000852	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—BCL2—polycystic ovary syndrome	0.000851	0.00158	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—INS—polycystic ovary syndrome	0.000846	0.00157	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000835	0.00155	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NRG1—polycystic ovary syndrome	0.000826	0.00154	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—CRP—polycystic ovary syndrome	0.000824	0.00153	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—IL6—polycystic ovary syndrome	0.000817	0.00152	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000793	0.00147	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000793	0.00147	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00078	0.00145	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—SERPINE1—polycystic ovary syndrome	0.000777	0.00145	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—IRS2—polycystic ovary syndrome	0.000767	0.00143	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—NRG1—polycystic ovary syndrome	0.000765	0.00142	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GP1BB—polycystic ovary syndrome	0.000749	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ATF1—polycystic ovary syndrome	0.000748	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—IRS2—polycystic ovary syndrome	0.000742	0.00138	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000729	0.00136	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IRS2—polycystic ovary syndrome	0.000708	0.00132	CbGpPWpGaD
Auranofin—IKBKB—Immune System—UBE2H—polycystic ovary syndrome	0.000704	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FBXO44—polycystic ovary syndrome	0.000704	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RACGAP1—polycystic ovary syndrome	0.000703	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—TAB1—polycystic ovary syndrome	0.000702	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PRL—polycystic ovary syndrome	0.000696	0.00129	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT2—polycystic ovary syndrome	0.000694	0.00129	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NGFR—polycystic ovary syndrome	0.000691	0.00128	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—INS—polycystic ovary syndrome	0.000689	0.00128	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000688	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—IRS1—polycystic ovary syndrome	0.00067	0.00125	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—IRS2—polycystic ovary syndrome	0.000655	0.00122	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000654	0.00122	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000648	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—IRS1—polycystic ovary syndrome	0.000647	0.0012	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SERPINE1—polycystic ovary syndrome	0.000633	0.00118	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT2—polycystic ovary syndrome	0.00062	0.00115	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IRS1—polycystic ovary syndrome	0.000618	0.00115	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000616	0.00115	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000616	0.00115	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT2—polycystic ovary syndrome	0.000599	0.00111	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT2—polycystic ovary syndrome	0.000596	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGF18—polycystic ovary syndrome	0.000595	0.00111	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000586	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL18—polycystic ovary syndrome	0.000586	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTAFR—polycystic ovary syndrome	0.00058	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT2—polycystic ovary syndrome	0.000572	0.00106	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—IRS1—polycystic ovary syndrome	0.000572	0.00106	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGF18—polycystic ovary syndrome	0.000572	0.00106	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—IGF1—polycystic ovary syndrome	0.000571	0.00106	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NRG1—polycystic ovary syndrome	0.000563	0.00105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000549	0.00102	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000547	0.00102	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	0.000544	0.00101	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—GAB1—polycystic ovary syndrome	0.000544	0.00101	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—SERPINE1—polycystic ovary syndrome	0.000542	0.00101	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT2—polycystic ovary syndrome	0.000529	0.000984	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—GAB1—polycystic ovary syndrome	0.000522	0.000971	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	0.000517	0.000961	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000517	0.000961	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—polycystic ovary syndrome	0.000514	0.000956	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000503	0.000934	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PDE3B—polycystic ovary syndrome	0.000502	0.000934	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IRS2—polycystic ovary syndrome	0.00049	0.000912	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00049	0.000911	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TNRC6B—polycystic ovary syndrome	0.000486	0.000904	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IRS2—polycystic ovary syndrome	0.000482	0.000897	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NPB—polycystic ovary syndrome	0.00048	0.000893	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000467	0.000869	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—TNRC6B—polycystic ovary syndrome	0.000467	0.000868	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—polycystic ovary syndrome	0.000465	0.000865	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—polycystic ovary syndrome	0.000461	0.000857	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—polycystic ovary syndrome	0.000452	0.000841	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—polycystic ovary syndrome	0.000444	0.000826	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—polycystic ovary syndrome	0.000437	0.000812	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—polycystic ovary syndrome	0.000437	0.000812	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000434	0.000808	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	0.00043	0.0008	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—polycystic ovary syndrome	0.000429	0.000798	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IRS1—polycystic ovary syndrome	0.000428	0.000796	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ATF1—polycystic ovary syndrome	0.000427	0.000794	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RACGAP1—polycystic ovary syndrome	0.000427	0.000793	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IRS1—polycystic ovary syndrome	0.000421	0.000783	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—polycystic ovary syndrome	0.000412	0.000765	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000409	0.000761	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—polycystic ovary syndrome	0.000402	0.000747	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000401	0.000745	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000401	0.000745	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000397	0.000739	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TAB1—polycystic ovary syndrome	0.000394	0.000733	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT2—polycystic ovary syndrome	0.00039	0.000725	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—polycystic ovary syndrome	0.000384	0.000714	CbGpPWpGaD
Auranofin—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	0.00038	0.000706	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000375	0.000697	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.000373	0.000694	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—polycystic ovary syndrome	0.00037	0.000689	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.00037	0.000688	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000364	0.000677	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000362	0.000674	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.000355	0.000661	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000354	0.000658	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000354	0.000658	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—polycystic ovary syndrome	0.000348	0.000648	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	0.000347	0.000646	CbGpPWpGaD
Auranofin—ALB—Metabolism—SUOX—polycystic ovary syndrome	0.000347	0.000646	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGF18—polycystic ovary syndrome	0.000347	0.000645	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000345	0.000642	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000343	0.000638	CbGpPWpGaD
Auranofin—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	0.000323	0.0006	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000322	0.000599	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRG1—polycystic ovary syndrome	0.000321	0.000597	CbGpPWpGaD
Auranofin—IKBKB—Immune System—GAB1—polycystic ovary syndrome	0.000317	0.000589	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000316	0.000587	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.000314	0.000583	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—polycystic ovary syndrome	0.00031	0.000577	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRG1—polycystic ovary syndrome	0.000308	0.000573	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	0.000301	0.00056	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000295	0.000548	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000293	0.000546	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CAMK2D—polycystic ovary syndrome	0.000288	0.000535	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TNRC6B—polycystic ovary syndrome	0.000283	0.000527	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000279	0.00052	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000276	0.000513	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IRS2—polycystic ovary syndrome	0.000275	0.000512	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CRP—polycystic ovary syndrome	0.000275	0.000512	CbGpPWpGaD
Auranofin—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.000275	0.00051	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.000275	0.00051	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000268	0.000499	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—IRS2—polycystic ovary syndrome	0.000264	0.000491	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000264	0.000491	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.000263	0.000488	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FST—polycystic ovary syndrome	0.000261	0.000486	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00026	0.000483	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—polycystic ovary syndrome	0.000259	0.000481	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000258	0.00048	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LHB—polycystic ovary syndrome	0.000255	0.000475	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000253	0.000471	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000253	0.000471	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000249	0.000464	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ATF1—polycystic ovary syndrome	0.000249	0.000462	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000245	0.000455	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000242	0.000449	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000241	0.000447	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IRS1—polycystic ovary syndrome	0.00024	0.000447	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SCT—polycystic ovary syndrome	0.000239	0.000445	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000239	0.000445	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—IRS1—polycystic ovary syndrome	0.000231	0.000429	CbGpPWpGaD
Auranofin—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.00023	0.000428	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TAB1—polycystic ovary syndrome	0.000229	0.000427	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000228	0.000424	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRL—polycystic ovary syndrome	0.000227	0.000423	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000227	0.000423	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000224	0.000417	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000222	0.000413	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT2—polycystic ovary syndrome	0.000222	0.000413	CbGpPWpGaD
Auranofin—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000218	0.000406	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT2—polycystic ovary syndrome	0.000213	0.000397	CbGpPWpGaD
Auranofin—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000208	0.000387	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000208	0.000387	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000208	0.000386	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000206	0.000382	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000205	0.000381	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.000202	0.000375	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INSR—polycystic ovary syndrome	0.000196	0.000364	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2—polycystic ovary syndrome	0.000194	0.000361	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL18—polycystic ovary syndrome	0.000191	0.000356	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRG1—polycystic ovary syndrome	0.000187	0.000348	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000186	0.000346	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMMR—polycystic ovary syndrome	0.000185	0.000345	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000183	0.00034	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PGR—polycystic ovary syndrome	0.000181	0.000337	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	0.000179	0.000333	CbGpPWpGaD
Auranofin—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	0.000177	0.000329	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—polycystic ovary syndrome	0.000176	0.000328	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000175	0.000325	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000175	0.000325	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000168	0.000313	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000168	0.000313	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000166	0.000308	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000165	0.000308	CbGpPWpGaD
Auranofin—ALB—Metabolism—LHB—polycystic ovary syndrome	0.000161	0.0003	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000161	0.000299	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS2—polycystic ovary syndrome	0.00016	0.000298	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CRP—polycystic ovary syndrome	0.00016	0.000298	CbGpPWpGaD
Auranofin—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	0.000158	0.000293	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000157	0.000291	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	0.000153	0.000284	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000148	0.000276	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRL—polycystic ovary syndrome	0.000147	0.000273	CbGpPWpGaD
Auranofin—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	0.000141	0.000261	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS1—polycystic ovary syndrome	0.00014	0.00026	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000139	0.000259	CbGpPWpGaD
Auranofin—ALB—Metabolism—RRM2—polycystic ovary syndrome	0.000136	0.000253	CbGpPWpGaD
Auranofin—ALB—Metabolism—YAP1—polycystic ovary syndrome	0.000131	0.000244	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—polycystic ovary syndrome	0.000131	0.000243	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT2—polycystic ovary syndrome	0.00013	0.000243	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT2—polycystic ovary syndrome	0.000129	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000129	0.00024	CbGpPWpGaD
Auranofin—ALB—Metabolism—NAMPT—polycystic ovary syndrome	0.000126	0.000234	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000125	0.000233	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	0.000124	0.000231	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000124	0.000231	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000124	0.00023	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000123	0.000229	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000121	0.000225	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	0.000118	0.000219	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	0.000116	0.000215	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2—polycystic ovary syndrome	0.000113	0.00021	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000104	0.000193	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LEP—polycystic ovary syndrome	0.000101	0.000188	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—polycystic ovary syndrome	0.0001	0.000187	CbGpPWpGaD
Auranofin—ALB—Metabolism—TH—polycystic ovary syndrome	0.0001	0.000186	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	9.74e-05	0.000181	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	9.16e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS1—polycystic ovary syndrome	9.04e-05	0.000168	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—POMC—polycystic ovary syndrome	8.71e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INS—polycystic ovary syndrome	8.66e-05	0.000161	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	8.53e-05	0.000159	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—polycystic ovary syndrome	8.38e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT2—polycystic ovary syndrome	8.37e-05	0.000156	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNAS—polycystic ovary syndrome	8.17e-05	0.000152	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.95e-05	0.000148	CbGpPWpGaD
Auranofin—ALB—Metabolism—NCOR1—polycystic ovary syndrome	7.79e-05	0.000145	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	7.38e-05	0.000137	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—polycystic ovary syndrome	6.88e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—polycystic ovary syndrome	5.85e-05	0.000109	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—polycystic ovary syndrome	5.58e-05	0.000104	CbGpPWpGaD
Auranofin—ALB—Metabolism—POMC—polycystic ovary syndrome	5.5e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—INS—polycystic ovary syndrome	5.47e-05	0.000102	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.47e-05	0.000102	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—polycystic ovary syndrome	3.78e-05	7.04e-05	CbGpPWpGaD
